Brief: Teladoc Health Q3 EPS USD -0.28
Oct 29 (Reuters) - Teladoc Health Q3 adjusted EBITDA USD 69.909 million vs. IBES estimate USD 65.9 million. Q3 basic EPS USD -0.28 Q3 net income USD -49.507 million Q3 revenue USD 626.439 million vs. IBES estimate USD 626 million outlook FY revenue USD 2,510-2,539 million outlook FY EPS USD -1.25 to -1.1 outlook FY adjusted EBITDA USD 270-287 million outlook Q4 revenue USD 622-652 million outlook Q4 EPS USD -0.25 to -0.1 outlook Q4 adjusted EBITDA USD 73-90 million
Recent news on Teladoc Health
See all newsTeladoc appoints insurance executive Michael Grasher as CFO
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
U.S. STOCKS ON THE MOVE-Mastercard, Starbucks, Meta
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurt (updated)
U.S. STOCKS ON THE MOVE-Avery Dennison, Huntington Ingalls, XPO